अ

Welcome to Arth Vani

Choose your preferred language

Sponsored · Open a free Demat account & get ₹500 in stocks.Claim
अ
ArthVani
Nifty 5024,227.30.05%H 24,262.2 · L 24,203.6|Sensex77,645.520.08%H 77,753.18 · L 77,541.68|Bank Nifty58,002.40.1%H 58,228.65 · L 57,820.9|USD / INR₹96.340.1%H ₹96.45 · L ₹96.28|Gold Intl (10g)₹1,25,401.520.81%H ₹1,25,671 · L ₹1,24,001.46|Silver Intl (1kg)₹1,79,762.311.69%H ₹1,80,273.39 · L ₹1,74,635.98|Crude WTI₹7,914.540.4%H ₹7,971.38 · L ₹7,891.41|Bitcoin₹63,10,1181.12%H ₹63,45,464.64 · L ₹62,74,771.36|Ethereum₹1,85,1872.56%H ₹1,87,554.08 · L ₹1,82,819.92|Nifty 5024,227.30.05%H 24,262.2 · L 24,203.6|Sensex77,645.520.08%H 77,753.18 · L 77,541.68|Bank Nifty58,002.40.1%H 58,228.65 · L 57,820.9|USD / INR₹96.340.1%H ₹96.45 · L ₹96.28|Gold Intl (10g)₹1,25,401.520.81%H ₹1,25,671 · L ₹1,24,001.46|Silver Intl (1kg)₹1,79,762.311.69%H ₹1,80,273.39 · L ₹1,74,635.98|Crude WTI₹7,914.540.4%H ₹7,971.38 · L ₹7,891.41|Bitcoin₹63,10,1181.12%H ₹63,45,464.64 · L ₹62,74,771.36|Ethereum₹1,85,1872.56%H ₹1,87,554.08 · L ₹1,82,819.92|
Breaking₹45.8 Lakh Today or ₹91.6 Lakh in 20 Years? Navigating Your Financial Choice1/6
Topicin real-estate

Natco Pharma

Latest news, explainers and analysis on Natco Pharma. Tracking 1 stories on Arth Vani.

1 stories tracked

Latest on Natco Pharma

Alembic & NATCO Get USFDA Nod for Cancer Drug; Big Market Opportunity
real-estate

Alembic & NATCO Get USFDA Nod for Cancer Drug; Big Market Opportunity

Indian pharmaceutical firms Alembic Pharmaceuticals and NATCO Pharma have received tentative USFDA approval for a generic version of the cancer drug Olaparib. This approval opens up a significant market opportunity in the US, estimated at ₹11,660 crore, though the commercial launch is contingent on ongoing legal proceedings.

1d ago·2 min readListen
real-estate products
Compare & act on the right product for this topic
Smart picks
HDFC NIFTY Next 50 Index Fund
HDFC Mutual Fund · Index
18.2%
3Y CAGR
Nippon India Small Cap Fund Growth Plan
Nippon India Mutual Fund · Small Cap
17.6%
3Y CAGR
Parag Parikh Flexi Cap Fund
PPFAS Mutual Fund · Flexi Cap
14.5%
3Y CAGR
Mirae Asset ELSS Tax Saver Fund
Mirae Asset Mutual Fund · ELSS
14.2%
3Y CAGR
HDFC Balanced Advantage Fund
HDFC Mutual Fund · Hybrid
13.9%
3Y CAGR
ICICI Prudential Balanced Advantage Fund
ICICI Prudential Mutual Fund · Hybrid
12.1%
3Y CAGR
Compare & decide
All comparisons
Read comparison

Loan interest rates, processing fees and eligibility are set by the lender and subject to credit approval — verify current terms before applying. Some listings may be sponsored. Not financial advice.

Explore all entities in the Knowledge Graph

Daily 3-minute money update on WhatsApp

Join 50,000+ investors — free.